MedPath logo

CUTIVATE CREAM 0.05% w/w

Prescription Only
Drug type: Therapeutic
ATC code: D07AC17
Dosage form: CREAM
Route of administration: TOPICAL
Active ingredient: FLUTICASONE PROPIONATE

Indications

TREATMENT OF INFLAMMATORY DERMATOSES

CUTIVATE Cream is indicated for adults and children for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses such as:

  • Eczema including atopic, infantile, and discoid eczemas

  • Prurigo nodularis

  • Psoriasis (excluding widespread plaque psoriasis)

  • Neurodermatoses including lichen simplex

  • Lichen planus

  • Seborrhoeic dermatitis

  • Contact sensitivity reactions

  • Discoid lupus erythematosus

  • An adjunct to systemic steroid therapy in generalised erythroderma

  • Insect bite reactions

  • Prickly heat

Contraindications

The following conditions should not be treated with CUTIVATE Cream:

  • Rosacea

  • Acne vulgaris

  • Perioral dermatitis

  • Primary cutaneous viral infections (e.g. herpes simplex, chickenpox)

  • Hypersensitivity to any of the ingredients

  • Perianal and genital pruritus

  • Pruritus without inflammation

  • The use of CUTIVATE Cream is not indicated in the treatment of primary infected skin lesions caused by infection with fungi or bacteria.

  • Dermatoses in children under one year of age, including dermatitis and napkin rash.

Dosage and Administration

Pharmaceutical form: Cream

For eczema/dermatitis, apply a thin film of CUTIVATE Cream to the affected skin areas once daily.

For all other indications, apply a thin film of CUTIVATE Cream to the affected skin areas twice daily.

Calculation of the appropriate dosage for children should allow for their greater surface area to body weight ratio.

Registrant
GLAXOSMITHKLINE PTE LTD
Approval Date
1996-03-26
Approval Number
SIN08628P
Manufacturer
GLAXO OPERATIONS UK LTD (TRADING AS GLAXO WELLCOME OPERATIONS)
Licence Holder
GLAXOSMITHKLINE PTE LTD